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Abstract Barley serpin BSZx is a potent inhibitor of trypsin 
and chymotrypsin at overlapping reactive sites (Dahl, S.W., 
Rasmussen, S.K. and Hejgaard, J. (1996) J. Biol. Chem., in 
press). We have now investigated the interactions of BSZx with a 
range of serine proteinases from human plasma, pancreas and 
leukocytes, a fungal trypsin and three subtilisins. Thrombin, 
plasma kallikrein, factor Vllaltissue factor and factor Xa were 
inhibited by BSZx at heparin independent association rates (kass) 
of 4.5 x 103-1.3 x 105 M - l  s i at 22°C. Only factor Xa turned a 
significant fraction of BSZx over as substrate. Complexes of 
these proteinase with BSZx resisted boiling in SDS, and amino 
acid sequencing showed that cleavage in the reactive center loop 
only occurred after PI Arg. Activated protein C and leukocyte 
clastase were slowly inhibited by BSZx (kass = I-2X 102 M - l  
s -t) whereas factor Xlla, urokinase and tissue type plasminogen 
activator, plasmin and pancreas kallikrein and elastase were not 
or only weakly affected. The inhibition pattern with mammalian 
proteinases reveal a specificity of BSZx similar to that of 
antithrombin III. Trypsin from Fusarium was not inhibited while 
interaction with subtilisin Carlsberg and Novo was rapid but 
most BSZx was cleaved as a substrate. Identification of a 
monoclonal antibody specific for native BSZx indicate that 
complex formation and loop cleavage result in similar conforma- 
tional changes. 
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I. Introduction 
Members of the serpin superfamily of se...£ine proteinase in....: 
hibitors have been identified in higher animals, insects, viruses 
and plants [1]. Most mammalian serpins function as regula- 
tors of complex physiological processes uch as blood coagu- 
lation, fibrinolysis and complement activation [2,3] whereas 
little is known about the biological activity and function of 
serpins from plants. Recently, three of the four identified 
plant serpins (BSZx [4] and BSZ4 [5] from barley and 
WSZ1 [6] from wheat) were expressed in E. coli and shown 
to possess inhibitory activities against rypsin (BSZx), chymo- 
trypsin (BSZx and WSZ1) and cathepsin G (BSZx, BSZ4 and 
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WSZ1) [7]. The atypical specificity of BSZx was due to over- 
lapping reactive centers. Inhibition of trypsin at P1 Arg pro- 
ceeded with a second order rate constant of 3.9 x 106 M -1 s -a 
and the rate of chymotrypsin inhibition, exclusively at P2 Leu, 
was only four times lower. In both cases ,~ 1 : 1 molar inhibi- 
tion stoichiometry was observed. Previously, overlapping cen- 
ters have only been observed in c~2- antiplasmin [8] and C1 
inhibitor [9]. In the present study, interactions of BSZx with 
mammalian and fungal proteinases of the chymotrypsin fam- 
ily as well as bacterial proteinases of the subtilisin family have 
been characterized. 
2. Materials and methods 
2.1. Biological materials 
BSZx was expressed from a genomic lone [4]. The genetic engineer- 
ing, expression in E. coli and purification to homogeneity by a com- 
bination of metal-chelate chromatography on a Ni2+-NTA column, 
gel filtration and anion exchange chromatography as been described 
recently [7]. Human urokinase-type lasminogen activator (u-PA) and 
porcine pancreas elastase were from Serva and human pancreas kal- 
likrein and leech eglin C from Sigma. Human antithrombin III (AT- 
III) and plasmin were from Kabi and human plasma kallikrein and 
human factor Xa were gifts from Dr. I. Schousboe, Copenhagen, 
Denmark, and Dr. W. Kisiel, Albuquerque, NM, USA, respectively. 
All other enzymes, recombinant soluble domain of human tissue fac- 
tor (sTF) and heparin were gifts from Novo Nordisk. Mono- and 
polyclonal antibodies towards BSZ4 [10] and BSZ7 [11] from barley 
grain and a polyclonal antibody against a pool of wheat serpins [12] 
were produced and purified according to standard procedures. 
2.2. Chemicals 
Substrates (see Table 1) were from Chromogenix except methoxy- 
succinyl-Ala-Ala-Pro-Val-p-nitroanilide and succinyl-Ala-Ala-Ala-p- 
nitroanilide which were from Sigma and succinyl-Ala-Ala-Pro-Phe- 
p-nitroanilide from Bachem. Secondary antibodies were from 
DAKO. Other chemicals used were of analytical grade. 
2.3. Inhibition assays and kinetic analyses 
Association rate constants were determined in discontinuous assays 
under either second or pseudo-first order conditions as previously 
described [7]. In short, BSZx and the proteinase were allowed to react 
for the times indicated after which the reaction was stopped by 5-25- 
fold dilution with 0.55 mM substrate solution. All reactions were 
performed at 22°C in 50 mM Tris-HC1, pH 8.0 and 100 mM NaCI. 
Tween 20 (0.1%) or bovine serum albumin (0.05%) was included ur- 
ing assays with trypsins or subtilisins, respectively. 5 mM CaC12 was 
included in assays with factor VIIa/sTF. The fraction (Xinh) of BSZx 
forming stable complex with an enzyme according to the suicide in- 
hibition scheme [13,14] was also determined except in cases of very 
slow inhibition. 
Concentrations of active trypsin, chymotrypsin, Fusarium trypsin 
and subtilisins were determined by active site titrations [15,16]. Con- 
centrations of the proteinase inhibitors BSZx, AT-III and eglin C and 
were determined by titrations against rypsin or chymotrypsin and, 
subsequently, titrated inhibitors were used to determine thrombin and 
factor Xa (AT-III) and leukocyte lastase (eglin C). Since no titration 
method was available for plasma kallikrein, the concentration of ac- 
tive enzyme was estimated by regression analysis of experimental data 
according to the model [7] assuming 1:1 inhibition stoichiometry. 
0014-5793/96l$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
PH SO0 1 4- 5793(96)00940-4  
166 S. 144 Dahl et al./FEBS Letters 394 (1996) 16~168 
Concentrations of the remaining enzymes were estimated by amino 
acid analyses of highly purified preparations. 
2.4. Complex formation and characterization 
Formation of enzyme-serpin complexes, tricine SDS-PAGE, immu- 
nological detection of BSZx on nitrocellulose membranes and amino 
acid sequencing of proteins and peptides blotted onto polyvinylidene 
difluoride membranes have been described previously [7,12]. For se- 
quencing of C-terminal peptides and complexes, samples were pre- 
pared by incubating 140 pmol of BSZx (6 lag) with ~ 120 pmol pro- 
teinase for 2(~30 min. 
3. Results 
3.1. Inhibition kinetics 
A range of serine proteinases from human blood, leuko- 
cytes and pancreas, one fungal trypsin and three Bacillus pro- 
teinases were analyzed for sensitivity to inhibit ion by BSZx 
(Table 1). BSZx was found to be a potent inhibitor of plasma 
kallikrein, thrombin and coagulation factors VI Ia/sTF and Xa 
and the interactions could be characterized under second or- 
der condit ions (Fig. 1). Among the proteinases tudied, kal- 
likrein was most rapidly inactivated (ka~ = 1.3× 105 M 1 s- l) .  
The kinetics of BSZx inhibit ion of thrombin and factor VIIa/ 
sTF were very similar with k~,~ values of 8 .0× 103 M -a s 
and 4.5×103 M -1 s -1, respectively, and inhibit ion stoichi- 
ometries close to 1 (Xinh -> 0.80). Factor Xa was inhibited at 
a similar association rate (k~ = 6.9 × 103 M -1 s 1) but ~ 80% 
was turned over as a substrate (Xinh = 0.17). Addit ion of 10 
gM heparin did not accelerate BSZx inhibit ion of thrombin or 
factor Xa in contrast o inhibit ion with AT-I I I  [17]. 
Activated protein C and leukocyte lastase were only slowly 
inhibited by BSZx (k~s = 1 -2× 102 M -1 s -1) which required 
determination of the association rates constants under pseudo 
first order conditions and prevented estimation of Xin h. Co ° 
agulation factor XI Ia  and u-PA were only weakly affected 
after incubation with BSZx in large excess, and no change 
in activity was observed for plasmin, t-PA and for the pan- 
creas enzymes elastase and kallikrein. 
In contrast to the fast inhibit ion of both pancreas trypsin 
and chymotrypsin [7], trypsin from the barley seed rot Fusa- 
rium oxysporum was not inactivated by BSZx which was 
cleaved as a substrate. Subtilisin Carlsberg and Novo 
(BPN')  were rapidly inhibited (Table 1) but the majority of 
BSZx molecules were turned over as a substrate (Xinh--<0.02). 
The reactions were completed in less than two minutes and no 
subsequent change in activity was observed for at least 20 
min. The subtilisin from B. pumilus showed no inhibit ion by 
BSZx. 
3.2. Serpin-proteinase complexes and cleavage sites 
Complexes of BSZx with thrombin,  plasma kallikrein, fac- 
tor VI Ia and factor Xa were resistant o boil ing in 1% SDS 
and subsequent SDS-PAGE (Fig. 2). Format ion of stable 
complexes was further confirmed by Western blott ing as in 
Fig. 3C and by amino acid sequencing of excised upper bands. 
In five sequencer cycles, only the N-terminal sequence of the 
proteinase domain (B-chain) of thrombin,  kallikrein, factor 
VI Ia and factor Xa, respectively, was detected besides the 
sequence of the histidine tag of BSZx. Reactive center loop 
cleavage sites were determined for the four enzymes by se- 
quencing the ,,0 4 kDa C-terminal peptides released by boil ing 
in SDS. With all enzymes, a single sequence: Ser-Leu-Pro- 
Val-Glu- was observed confirming that the Arg-Ser bond at 
P~ was the target site recognized by these proteinases. 
To further characterize complex formation with BSZx a 
Table 1 
Serpin-proteinase association rate constants (k,.~) and fractions of BSZx forming complex with proteinases (Xinh) 
Proteinase a Source b CBSZx (nM) C . . . . .  (nM) p-Nitroanilide substrate c k~ d (M -1 s 1) Xinh 
fVIIa/sTF H plasma 200 200 D-Ile-Pro-Arg- 4.5 × 10 a 0.80 
fXa H plasma 42.5 42.5 Z-D-Arg-Gly-Arg- 6.9 x 10 :t 0.17 
fXIIa H plasma 100 3 D-Pro-Phe-Arg- wi nd 
Thrombin H plasma 50 50 D-Phe-Pip-Arg- 8.0 X 103 1.0 
Kallikrein H plasma 10 3.2 D-Pro-Phe-Arg- 1.3 X 10 ~ 
APC H plasma 500 50 pyroGlu-Pro-Arg- 1.7 × 102 nd 
u-PA H plasma 100 3 pyroGlu-Gly-Arg- wi nd 
t-PA H plasma 100 5 D-lle-Pro-Arg- ni 
Plasmin H plasma 100 10 D-Val-Leu-Lys- ni 
Elastase P pancreas 100 5 suc-Ala-Ala-Ala- ni 
Kallikrein H pancreas 100 0.3U/ml D-Val-Leu-Arg- ni 
Trypsin a P pancreas 7.5 12.5 p-tosyI-Gly-Pro-Arg- 3.9 × 106 0.98 
Chymotrypsin a B pancreas 7.5 12.5 suc-Ala-Ala-Pro-Phe- 9.4× 105 0.98 
Elastase H leukocyte 500 50 msuc-Ala-Ala-Pro-Val- 1.3 × 102 nd 
Cathepsin G ~ H leukocyte 150 220 suc-Ala-Ala-Pro-Phe- 2.4 X 10 4 1.0 
Fungal trypsin F oxysporum 60 30 Bz-Ile-Glu(y-OR)-Gly-Arg- ni 
Sub SP226 B. pumilus 100 10 suc-Ala-Ala-Pro-Phe- ni 
Sub Carlsberg B. licheniformis 110 10 suc-Ala-Ala-Pro-Phe- nd 0.02 
Sub Novo R amyloliquefaciens 100 10 suc-Ala-Ala-Pro-Phe- nd 0.006 
The data were obtained under either second or pseudo-first order conditions at 22°C. See text for further information on individual enzymes and 
data analysis. 
~Results for trypsin, chymotrypsin and cathepsin G have been published previously and are included for comparison [7]. sub: subtilisin. 
USource organism: H, human; P, porcine; B, bovine; F., Fusarium; B., Bacillus. 
ON-terminal blocking groups: Z, carbobenzoxy; pyroGlu, pyroglutamyl; suc, succinyl; msuc, methoxysuccinyl; Bz, benzoyl. 
dwi, weak inhibition (~ 10%) or ni, no inhibition (< 5%) after 30 min; nd, not determined. 
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number of mono- and polyclonal antibodies towards native 
and cleaved forms of the barley serpins BSZ4 and BSZ7 were 
screened for interactions with BSZx by Western blotting. One 
monoclonal mouse antibody (8E8) raised against BSZ4 exhib- 
ited high affinity to native BSZx while no recognition of 
cleaved BSZx or of BSZx in complex with either thrombin, 
plasma kallikrein, factor VIIa, factor Xa and trypsin (Fig. 3) 
could be observed. Preincubation of BSZx (50 nM) with 8E8 
in ten-fold molar excess for 30 min at 22°C reduced the rate of 
thrombin inhibition (k~) by less than 20%. 
4. Discuss ion 
The barley serpin BSZx has not been identified in the plant 
and only obtained in a recombinant form [7]. The observed 
flexibility of the reactive center loop, which allowed for effi- 
cient inhibition of both trypsin and chymotrypsin at overlap- 
ping reactive centers, prompted us to investigate he inhibition 
of a range of serine proteinases. The inhibitory specificity of 
BSZx at P1 Arg towards coagulation factors (Table 1) was 
shown to be similar to that of AT-Ill. In addition to inhibi- 
tion of thrombin, plasma kallikrein, factor Xa and trypsin, 
BSZx and AT-III are, to our knowledge, the only reported 
serpin inhibitors of factor VIIa/sTF and both with association 
rates of ,~5× 103 M -1 s -1 [18]. However, BSZx is independ- 
ent on heparin. The experiments with factor Xa illustrate that 
a large fraction of the serpin molecules may be cleaved as a 
substrate at the inhibitory site in accordance with the suicide 
inhibition scheme and the kinetic model. BSZx contains a 
potential substrate site at P6 Arg, a position generally occu- 
pied by a hydrophobic residue [1], but no cleavage at this site 
could be detected with any of the four coagulation factors. 
The monoclonal ntibody 8E8 was specific for native BSZx 
and showed no affinity for cleaved BSZx or for any of five 
proteinase complexes (Fig. 3). BSZx retained nearly full activ- 
ity after preincubation with 8E8 in excess and, presumably, 
the epitope recognized by 8E8 is not located in the loop re- 
gion. More likely, partial or complete loop insertion caused 
by complex formation or cleavage results in a structural re- 
arrangement disrupting the epitope [19-21]. This suggestion is 
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Fig. 1. Inhibition of human coagulation factors by BSZx. 13, plasma 
kallikrein; V, factor VIIa/sTF; A, thrombin and +, factor Xa. De- 
termination of k~ and Xinh by non-linear egression was done as 
reported previously [7]. Experimental details and the derived kinetic 
constants are given in Table 1. 
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Fig. 2. Formation of SDS-stable complexes with coagulation factors. 
BSZx was incubated with 15 pmol enzyme at 22°C for 20 min be- 
fore addition of reducing sample buffer, boiling for 4 min and tri- 
cine SDS-PAGE. Lane 1:6 pmol BSZx; lanes 24, 15 pmol BSZx 
incubated with thrombin, plasma kallikrein and factor VIIa/sTF, re- 
spectively; lane 5:30 pmol BSZx incubated with factor Xa. The 
bands were visualized by silver staining. The positions of intact 
complexes (C), partially degraded complexes (C*), intact BSZx (I), 
cleaved BSZx (I*) and released C-terminal peptides (P) are indicated 
on the right. 
corroborated by reports on monoclonal antibodies recogniz- 
ing neoantigenic epitopes on C1 inhibitor and PAI-1 gener- 
ated both by cleavage of the reactive center loop and by 
complex formation [22,23]. 
Mammalian and Fusarium trypsins are very similar in their 
secondary structural elements and overall conformation but 
significant differences are observed in the active site region 
[24]. Although Fusarium trypsin preferentially binds Arg in 
the specificity pocket and is inhibited by the very different 
Kunitz inhibitors of pancreas and soy bean [24], no inhibition 
by BSZx was observed. Recently cq-proteinase inhibitor and 
cq-antichymotrypsin were shown to inhibit and form SDS 
stable complexes with subtilisins [25]. The interactions of sub- 
tilisins both with BSZx and the mammalian serpins were char- 
acterized by fast associations but inefficient inhibition as more 
than 90% of the serpin molecules were turned over as sub- 
strate (Xinh was 0.02 (BSZx) and 0.08 (cq-proteinase inhibitor 
[25]) for interaction with subtilisin Carlsberg at 22°C). 
In conclusion, kinetic studies have shown that recombinant 
BSZx inhibits and forms SDS-stable complexes with several 
human coagulation factors. The specificity is similar to that of 
antithrombin III and BSZx interacted with the proteinases 
and pancreas trypsin exclusively at P1 Arg. However, BSZx 
is also an effective inhibitor of chymotrypsin and cathepsin G
at P2 Leu [7] and the slow interaction with leukocyte lastase 
is assumed to occur at this overlapping site. 
The other known plant serpins, BSZ7 and BSZ7 from bar- 
ley and WSZ1 from wheat, are expressed in large amounts in 
the cereal grain endospenns [10-12]. Target proteinases have 
not been identified in the resting or germinating grain and a 
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Fig. 3. Immunological recognition of native, cleaved and complex- 
bound BSZx. Samples of 13 pmol BSZx (lane 1) or 26 pmol BSZx 
incubated with 23 pmol trypsin (lane 2) were subjected to SDS- 
PAGE and detected by either silver staining (A) or by Western blot- 
ting. The monoclonal antibody 8E8 (B) only reacted with native 
BSZx whereas the polyclonal antibody 337 (C) recognized native 
and all proteolytically modified forms of both BSZx and BSZx in 
complex with trypsin. The different molecular species are indicated 
as in Fig. 2. 
role in plant defence has been suggested. Neither BSZx nor a 
cDNA encoding this serpin has been detected in grain tissues 
but the BSZx promoter is functional in transgenic tobacco 
(S.K. Rasmussen, unpublished). BSZx is a potent inhibitor 
but was inefficient against the tested microbial enzymes of 
both the chymotrypsin and the subtilisin family. These obser- 
vations indicate that BSZx may have a specific regulatory role 
in the plant and a search for tissue and time specific expres- 
sion of BSZx as well as endogenous target proteinases has 
been initiated. 
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